These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Pyridostigmine partially restores the GH responsiveness to GHRH in normal aging. Ghigo E, Goffi S, Arvat E, Nicolosi M, Procopio M, Bellone J, Imperiale E, Mazza E, Baracchi G, Camanni F. Acta Endocrinol (Copenh); 1990 Aug; 123(2):169-73. PubMed ID: 2220258 [Abstract] [Full Text] [Related]
4. Low hexarelin dose and pyridostigmine have additive effect and potentiate to the same extent the GHRH-induced GH response in man. Arvat E, Di Vito L, Ramunni J, Gianotti L, Giordano R, Deghenghi R, Camanni F, Ghigo E. Clin Endocrinol (Oxf); 1997 Oct; 47(4):495-500. PubMed ID: 9404449 [Abstract] [Full Text] [Related]
6. Arginine but not pyridostigmine, a cholinesterase inhibitor, enhances the GHRH-induced GH rise in patients with anorexia nervosa. Ghigo E, Arvat E, Gianotti L, Nicolosi M, Valetto MR, Avagnina S, Bellitti D, Rolla M, Müller EE, Camanni F. Biol Psychiatry; 1994 Nov 15; 36(10):689-95. PubMed ID: 7880938 [Abstract] [Full Text] [Related]
12. The role of cholinergic tone in modulating the growth hormone response to growth hormone-releasing hormone in normal man. Giustina A, Bossoni S, Bodini C, Doga M, Girelli A, Buffoli MG, Schettino M, Wehrenberg WB. Metabolism; 1991 May 15; 40(5):519-23. PubMed ID: 2023538 [Abstract] [Full Text] [Related]
15. Short-term fasting in obesity fails to restore the blunted GH responsiveness to GH-releasing hormone alone or combined with arginine. Procopio M, Maccario M, Grottoli S, Oleandri SE, Boffano GM, Camanni F, Ghigo E. Clin Endocrinol (Oxf); 1995 Dec 15; 43(6):665-9. PubMed ID: 8736266 [Abstract] [Full Text] [Related]